Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

PubMed Links for Books (Select 2374952)

1.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A; B S R B R Control Centre Consortium, Symmons DP; BSR Biologics Register.

Ann Rheum Dis. 2010 Mar;69(3):522-8. doi: 10.1136/ard.2009.118935. Epub 2009 Oct 22.

2.

Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM.

JAMA. 2009 Apr 22;301(16):1661-70. doi: 10.1001/jama.2009.547.

3.

Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.

Hauben M, Aronson JK.

Drug Saf. 2009;32(2):99-110. doi: 10.2165/00002018-200932020-00003. Review.

PMID:
19236117
4.

European biologicals registers: methodology, selected results and perspectives.

Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DP.

Ann Rheum Dis. 2009 Aug;68(8):1240-6. doi: 10.1136/ard.2008.091926. Epub 2008 Jul 22. Review.

PMID:
18647854
5.

Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.

Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH.

Drugs Aging. 2008;25(4):343-55.

PMID:
18361544
6.

Results of European post-marketing surveillance of bosentan in pulmonary hypertension.

Humbert M, Segal ES, Kiely DG, Carlsen J, Schwierin B, Hoeper MM.

Eur Respir J. 2007 Aug;30(2):338-44. Epub 2007 May 15.

7.

Drug safety reform at the FDA--pendulum swing or systematic improvement?

McClellan M.

N Engl J Med. 2007 Apr 26;356(17):1700-2. Epub 2007 Apr 13. No abstract available.

8.

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L; SCAAR Study Group.

N Engl J Med. 2007 Mar 8;356(10):1009-19. Epub 2007 Feb 12.

9.

The antiretrovirals in pregnancy registry: a fifteenth anniversary celebration.

Tilson HH, Doi PA, Covington DL, Parker A, Shields K, White A.

Obstet Gynecol Surv. 2007 Feb;62(2):137-48.

PMID:
17229330
10.

Psoriasis therapy in real life: the need for registries.

Schmitt-Egenolf M.

Dermatology. 2006;213(4):327-30.

PMID:
17135739
11.

An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Figueiras A, Herdeiro MT, Polónia J, Gestal-Otero JJ.

JAMA. 2006 Sep 6;296(9):1086-93.

PMID:
16954488
12.

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Kleinschmidt-DeMasters BK, Tyler KL.

N Engl J Med. 2005 Jul 28;353(4):369-74. Epub 2005 Jun 9.

13.

Severely suppressed bone turnover: a potential complication of alendronate therapy.

Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY.

J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301. Epub 2004 Dec 14.

PMID:
15598694
14.

THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.

FINNEY DJ.

J Chronic Dis. 1965 Jan;18:77-98. No abstract available.

PMID:
14252273
15.

Phocomelia and internal defects due to thalidomide.

LECUTIER MA.

Br Med J. 1962 Dec 1;2(5317):1447-8. No abstract available.

16.

Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole.

Moore N, Hall G, Sturkenboom M, Mann R, Lagnaoui R, Begaud B.

Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):271-81.

PMID:
12812006
17.

Quantitative methods in pharmacovigilance: focus on signal detection.

Hauben M, Zhou X.

Drug Saf. 2003;26(3):159-86. Review.

PMID:
12580646
19.

Attitudinal survey of voluntary reporting of adverse drug reactions.

Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH.

Br J Clin Pharmacol. 1999 Oct;48(4):623-7.

20.

Principles of signal detection in pharmacovigilance.

Meyboom RH, Egberts AC, Edwards IR, Hekster YA, de Koning FH, Gribnau FW.

Drug Saf. 1997 Jun;16(6):355-65. Review.

PMID:
9241490
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk